Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 32.78 | 13.49 |
| PEG Ratio (TTM) | -2.38 | 2.87 |
| P/S Ratio (TTM) | 0.81 | 1.61 |
| P/B Ratio (TTM) | 6.30 | 2.75 |
| P/FCF Ratio (TTM) | 5.20 | 7.50 |
| Price to 5YR AVG Earnings Ratio | N/A | 20.43 |
| Price to 5YR AVG FCF Ratio | N/A | 11.76 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.57% | 4.45% |
| ROE (TTM) | 16.82% | 21.60% |
| Net Profit Margin (TTM) | 2.46% | 11.44% |
| ROIC 5YR AVG | N/A | 10.65% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 165.80% | -213.02% | N/A |
| Revenue | 4.34% | 24.28% | N/A |
| Net Income | 219.53% | -204.06% | N/A |
| Cash Flow | 73.35% | 9.13% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | 14.48 |
| Quick Ratio (TTM) | 1.01 | 14.48 |
| D/E Ratio (TTM) | 0.18 | 0.38 |
| Interest Coverage (TTM) | 2.46 | 19.88 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 0.85 | 1.58 |
| LTL to 5YR AVG FCF | N/A | 1.40 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.23% |